AU Patent

AU2018256518A1 — Nasal drug delivery device

Assigned to Impel Pharmaceuticals Inc · Expires 2018-11-22 · 7y expired

What this patent protects

H tde liencVcWNRPonhlCOtDEPI h2f7I .dcn7l l)Il A device for delivering a compound to an olfactory region of a nasal cavity comprising: a canister capable of containing a propellant, a diffuser in communication with the canister, a compound chamber in communication with the diffus…

USPTO Abstract

H tde liencVcWNRPonhlCOtDEPI h2f7I .dcn7l l)Il A device for delivering a compound to an olfactory region of a nasal cavity comprising: a canister capable of containing a propellant, a diffuser in communication with the canister, a compound chamber in communication with the diffuser, the compound chamber capable of containing the compound, and a nozzle in communication with the compound chamber, wherein the device is capable of delivering the compound to the olfactory region of the nasal cavity.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018256518A1
Jurisdiction
AU
Classification
—
Expires
2018-11-22
Drug substance claim
No
Drug product claim
No
Assignee
Impel Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.